Last updated on April 2018

Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD

Brief description of study

The purpose of this study is to evaluate the safety and effectiveness of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD) in the real world clinical setting in Japan.

Clinical Study Identifier: NCT02847624

Find a site near you

Start Over